IVVD
Invivyd, Inc.NASDAQHealthcare$1.28-3.76%ClosedMarket Cap: $169.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.93
P/S
3.23
EV/EBITDA
0.98
DCF Value
$11.53
FCF Yield
-33.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
93.0%
Operating Margin
-104.0%
Net Margin
-98.2%
ROE
-48.7%
ROA
-19.0%
ROIC
-22.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $17.2M | 93.4% | $-12.6M | $-11.1M | $-0.06 | — |
| FY 2025 | $53.4M | 93.0% | $-55.6M | $-52.5M | $-0.30 | — |
| Q3 2025 | $13.1M | 91.7% | $-11.0M | $-10.5M | $-0.06 | — |
| Q2 2025 | $11.8M | 94.2% | $-15.1M | $-14.7M | $-0.12 | — |
| Q1 2025 | $11.3M | 92.6% | $-16.9M | $-16.3M | $-0.14 | — |
| Q4 2024 | $13.8M | 94.8% | $-19.2M | $-18.4M | $-0.15 | — |
| FY 2024 | $25.4M | 93.6% | $-176.9M | $-169.9M | $-1.43 | — |
| Q3 2024 | $9.3M | 91.3% | $-62.3M | $-60.7M | $-0.51 | — |
| Q2 2024 | $2.3M | 96.1% | $-49.2M | $-47.2M | $-0.40 | — |
| Q1 2024 | $0.00 | NaN% | $-46.1M | $-43.5M | $-0.38 | — |
| Q4 2023 | $0.00 | NaN% | $-76.8M | $-73.7M | $-0.67 | — |
| FY 2023 | $0.00 | NaN% | $-212.8M | $-198.6M | $-1.81 | — |